Comparison of Adipose Stromal Vascular Fraction and Placental Cell Extract to Expanded Adipose, Placental, and Umbilical Cord Mesenchymal Stem Cells

Abstract Multipotent mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including osteoarthritis and other conditions, while the crude preparation of MSCs, the “stromal vascular fraction” (SVF) [...]

2018-05-07T15:01:13+00:00 May 7th, 2018|

Vitro Biopharma Debt Re-Capitalization and Executive Team Formation

Golden, Colorado-May 3rd, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, (the “Company”) announced today the details of its balance sheet re-capitalization and the formation of its executive team effective April 30th , 2018. The Company’s founder and C.E.O. have agreed to recapitalize $1,003,119 in advances to the Company that were made during the Research [...]

2018-05-07T14:37:08+00:00 May 7th, 2018|

Vitro Biopharma 1st Quarter 2018 Financial Results of Operations

Golden, Colorado-March 20, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2018 financial results of operations. Vitro Diagnostics Inc. (“Vitro”) is pleased to announce a record 1st quarter in Stem Cell Revenues. Vitro recorded 1st quarter revenues of $87,185 vs $57,041 an increase of 53% over the same [...]

2018-05-07T18:00:51+00:00 April 4th, 2018|

Stem Cell Activation by Natural Products

Abstract Bone marrow stem cell therapies, based on transplant of hematopoietic stem cells (HSCs) have been used for over 50 years in the treatment of blood disorders including leukemia, lymphoma, and auto-immune disorders. Embryonic stem cells (ESCs) were discovered in the late 1990’s by Evans, Kauffman, and Martin. J Thompson developed procedures to isolate and [...]

2018-04-04T22:15:42+00:00 April 4th, 2018|

Stem Cell Activation by NutraVivo™ Dietary Supplements

Stem cell therapies and regenerative medicine are new and upcoming medical treatments. Stem cells are undifferentiated cells that reside throughout the body that give rise to other kinds of cell types (neurons, heart cells, bone cells, etc.) Recently these cells have been studied for anti-aging effects, reversing blindness, regenerating cartilage, etc. Bone marrow derived stem [...]

2018-05-07T18:00:51+00:00 March 27th, 2018|

2017 CEO Shareholder Letter: Translation from R&D to Stem Cell Therapies Accelerates Revenue and Prospects for Future Growth

Golden, Colorado—December 20, 2017—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its CEO letter to its shareholders including discussion of 2016 & 2017 results and plans for 2018 including regenerative medicine initiatives for expanding indications. Dear Shareholders, In 2016-2017 we achieved: Accelerated translation from research products to stem cell therapies. Expansion of our facility [...]

2018-05-07T18:00:51+00:00 December 27th, 2017|

Immunotherapy of Solid Tumor Cancers: Role of Cancer Associated Fibroblasts

Cancer therapy traditionally involves surgery, radiation or chemotherapy to kill cancer cells that are normal cells lacking control that limit growth.  Cancer cells produce continually growing tumors that spread to other tissues, and eventually kill. Since the early 1990’s, other targeted therapies have been developed with fewer side-effects. During 2017, the first CAR-T immunotherapies were [...]

2018-03-06T00:38:13+00:00 December 12th, 2017|

Vitro Biopharma Files Patent for its Novel Stem Cell Line with Broad Application to Stem Cell Therapies

Golden, Colorado—November 21, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the filing of a USPTO patent application regarding a novel stem cell line and its application to treatment of a variety of conditions including skeletal muscular, neurological, immune system dysfunction and other diseases or injuries as well.  The new stem cell line [...]

2018-05-07T18:00:51+00:00 November 29th, 2017|

Anti-Aging Stem Cell Therapy Improves Quality of Life

Scientists at the University of Miami Miller School of Medicine completed a clinical trial showing safety and efficacy of stem cell therapy in treatment of frailty, a common aging symptom caused by reduced function of stem cells and inflammation.1 Stem cells in the body serve several functions including repair and regeneration of damaged tissues, production [...]

2018-03-06T00:43:54+00:00 October 31st, 2017|

Vitro Biopharma Reports Positive Clinical Trial Results of Stem Cell Activation Therapy for Autism

Golden, Colorado—August 8, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced initial results of a Phase I clinical trial testing the effects of its proprietary stem cell activation compounds for safety and efficacy in autistic patients. Safety was the primary endpoint of our non-randomized, pilot study and our preliminary data indicate a low [...]

2018-05-07T18:00:51+00:00 August 9th, 2017|